|
OMIM |
Link |
Information gain |
01 |
|
nephrolithiasis, calcium oxalate
|
[NCBI]
|
0.00344512
|
|
|
SHEP8
|
[NCBI]
|
0.00264194
|
|
|
CHED1
|
[NCBI]
|
0.00192174
|
|
|
glycogen storage disease ic
|
[NCBI]
|
0.000692014
|
|
|
G6PT1
|
[NCBI]
|
0.000670764
|
|
|
glycogen storage disease ib
|
[NCBI]
|
0.00056011
|
|
|
SLC26A3
|
[NCBI]
|
0.000504845
|
|
|
CHED2
|
[NCBI]
|
0.000456818
|
|
|
SHEP3
|
[NCBI]
|
0.000431406
|
|
|
SHEP1
|
[NCBI]
|
0.000368949
|
|
|
SHEP4
|
[NCBI]
|
0.000338099
|
|
|
SLCO2A1
|
[NCBI]
|
0.000318505
|
|
|
RTADR
|
[NCBI]
|
0.000261455
|
|
|
SLC4A3
|
[NCBI]
|
0.00023565
|
|
|
SLC4A11
|
[NCBI]
|
0.000194587
|
|
|
PNKD1
|
[NCBI]
|
0.000190178
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
0.000190178
|
|
|
corneal dystrophy and perceptive deafness
|
[NCBI]
|
0.00016875
|
|
|
SHEP6
|
[NCBI]
|
0.00016875
|
|
|
SHEP7
|
[NCBI]
|
0.00016875
|
|
|
hypertension, essential
|
[NCBI]
|
0.000143858
|
|
|
SLC4A2
|
[NCBI]
|
0.000137465
|
|
|
TAPBP
|
[NCBI]
|
0.000137465
|
|
|
pseudodiastrophic dysplasia
|
[NCBI]
|
0.000137172
|
|
|
SHEP5
|
[NCBI]
|
0.000125262
|
|
|
bare lymphocyte syndrome, type i
|
[NCBI]
|
0.000117532
|
|
|
renal tubular acidosis, distal, with hemolytic anemia
|
[NCBI]
|
0.000111788
|
|
|
solute carrier family 26 (anion transporter), member 6: slc26a6
|
[NCBI]
|
0.000107274
|
|
|
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation
|
[NCBI]
|
0.000107213
|
|
|
acyl-coa dehydrogenase, long-chain, deficiency of
|
[NCBI]
|
0.000103411
|
|
|
CFTR
|
[NCBI]
|
0.000100681
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
9.73159e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
8.8575e-05
|
|
|
SHEP2
|
[NCBI]
|
8.52186e-05
|
|
|
SLC26A7
|
[NCBI]
|
8.34779e-05
|
|
|
SLC26A8
|
[NCBI]
|
8.34779e-05
|
|
|
SLC41A1
|
[NCBI]
|
8.34779e-05
|
|
|
CF
|
[NCBI]
|
7.33392e-05
|
|
|
SLC24A5
|
[NCBI]
|
7.32547e-05
|
|
|
SLC24A4
|
[NCBI]
|
7.32547e-05
|
|
|
SLC4A1
|
[NCBI]
|
5.75689e-05
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
5.403e-05
|
|
|
LPI
|
[NCBI]
|
4.67889e-05
|
|
|
SLC26A9
|
[NCBI]
|
4.17149e-05
|
|
|
SLC41A3
|
[NCBI]
|
4.17149e-05
|
|
|
SLC25A23
|
[NCBI]
|
4.17149e-05
|
|
|
SLC4A1AP
|
[NCBI]
|
4.17149e-05
|
|
|
SLC25A24
|
[NCBI]
|
4.17149e-05
|
|
|
ZBTB22
|
[NCBI]
|
4.17149e-05
|
|
|
SLC9A7
|
[NCBI]
|
4.17149e-05
|
|
|
PFDN6
|
[NCBI]
|
4.17149e-05
|
|
|
AQP4
|
[NCBI]
|
3.54635e-05
|
|
|
SLC4A9
|
[NCBI]
|
3.42935e-05
|
|
|
WDR46
|
[NCBI]
|
3.42935e-05
|
|
|
SLC41A2
|
[NCBI]
|
3.42935e-05
|
|
|
RACGAP1
|
[NCBI]
|
3.14938e-05
|
|
|
RGL2
|
[NCBI]
|
3.14938e-05
|
|
|
HERC2
|
[NCBI]
|
3.14938e-05
|
|
|
SLC25A25
|
[NCBI]
|
3.14938e-05
|
|
|
ATP6V0A4
|
[NCBI]
|
3.14938e-05
|
|
|
TYR
|
[NCBI]
|
3.07775e-05
|
|
|
ABCC2
|
[NCBI]
|
3.00886e-05
|
|
|
myofibrillogenesis regulator 1
|
[NCBI]
|
2.72495e-05
|
|
|
PDZK1
|
[NCBI]
|
2.49207e-05
|
|
|
DAXX
|
[NCBI]
|
2.49207e-05
|
|
|
SLC4A4
|
[NCBI]
|
2.37925e-05
|
|
|
SLC26A2
|
[NCBI]
|
2.17169e-05
|
|
|
SLC45A2
|
[NCBI]
|
2.13842e-05
|
|
|
oca2 gene
|
[NCBI]
|
1.84835e-05
|
|
|
FOXO1A
|
[NCBI]
|
1.70336e-05
|
|
|
AGT
|
[NCBI]
|
1.53656e-05
|
|
|
RP
|
[NCBI]
|
1.50189e-05
|
|
|
SLC2A2
|
[NCBI]
|
1.41088e-05
|
|
|
AQP1
|
[NCBI]
|
1.21558e-05
|
|
|
HNF1A
|
[NCBI]
|
1.21022e-05
|
|
|
EGF
|
[NCBI]
|
1.1727e-05
|
|
|
TNF
|
[NCBI]
|
1.15192e-05
|
|
|
ABCB11
|
[NCBI]
|
1.15011e-05
|
|
|
MC1R
|
[NCBI]
|
1.14541e-05
|
|
|
KITLG
|
[NCBI]
|
8.98971e-06
|
|
|
HP
|
[NCBI]
|
3.81099e-06
|
|
|
NGFB
|
[NCBI]
|
3.62135e-06
|
|
|
PTH
|
[NCBI]
|
3.01907e-06
|
|
|
MUC1
|
[NCBI]
|
3.01341e-06
|
|
|
AVP
|
[NCBI]
|
2.03125e-06
|
|
|
PPARA
|
[NCBI]
|
1.48573e-06
|
|
|
CEACAM5
|
[NCBI]
|
1.18681e-06
|
|
|
TH
|
[NCBI]
|
8.69084e-07
|
|
|
APOE
|
[NCBI]
|
9.00612e-09
|
|